The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rajavelu Esther since 2024.
This trader's CIK number is 1903716.
At the time of last reporting, Rajavelu Esther was the CFO & CBO of Spero Therapeutics, Inc.. (stock ticker symbol SPRO).
Also see all insider trading activities at Spero Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | SPRO | 0 | $0 | 20,689 | $16,137 | 0 | $0 |
2024 | SPRO | 0 | $0 | 40,596 | $53,007 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-05 | SPRO | Sale | 20,689 | .78 | 16,137 |
2024-11-08 | SPRO | Sale | 17,245 | 1.30 | 22,418 |
2024-11-07 | SPRO | Sale | 23,351 | 1.31 | 30,589 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rajavelu Esther (CFO & CBO of Spero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.